Pull to refresh
Logo
What Changed
Following Why Sign Up
Court approves generic drug settlement distribution plan

Court approves generic drug settlement distribution plan

Rule Changes

Consumers who bought certain generic drugs from 2009 to 2019 can file claims

October 16th, 2026: Judge grants preliminary approval to Sandoz settlement

Overview

Updated Oct 25

People who bought certain generic prescription drugs in the United States between May 2009 and December 2019 can file claims for settlement money until March 8, 2027. A federal court in Connecticut has given preliminary approval to the plans for dividing that money up.

Settlements with Sandoz, Glenmark, Lannett, Bausch, Apotex, Heritage and Emcure total $496.5 million. In October, more than 40 states asked the court to approve separate deals with Ascend Laboratories, Citron Pharma and Mayne Pharma; the announcements did not give amounts. No receipts are needed for the basic claim, though people who ask for a payment based on their spending may have to document it later.

Why it matters

If you bought generic drugs in the U.S. from 2009 to 2019, you may be owed money from these settlements.

Questions about this story

Free account needed to ask — your question is kept and asked for you right after sign-up. Answers are public.

No questions yet — be the first to ask.

Key Indicators

$496.5M
Settlement funds so far
Sandoz ($400M) plus Glenmark, Lannett, Bausch, Apotex, Heritage and Emcure ($96.5M); newer deals with Ascend, Citron and Mayne have no disclosed amount
48
States and territories in coalition
Bipartisan coalition led by Connecticut; California and 47 others filed the distribution plan
10
Years of purchases covered
May 2009 to December 2019

Voices

Curated perspectives — historical figures and your fellow readers.

Sign up to generate historical perspectives on this story.

Log in Sign Up

People Involved

Rob Bonta
Rob Bonta
California Attorney General
Urged Californians to file claims; the coalition itself is led by Connecticut
 Dan Rayfield
Dan Rayfield
Oregon Attorney General
Announced the Sandoz settlement
 Letitia James
Letitia James
New York Attorney General
Encouraging New Yorkers to file claims
 Raúl Labrador
Raúl Labrador
Idaho Attorney General
Announced the settlements and urged Idahoans to file claims

Organizations Involved

Sandoz Inc.
Sandoz Inc.
Pharmaceutical manufacturer
Settled for $400 million

Generic drug manufacturer that agreed to pay $400 million to settle price-fixing allegations.
SA
State Attorney General Coalition
Multi-State Litigation Coalition
Filing settlements and running the claims process

Coalition of 48 states and territories in the generic-drug antitrust cases, led by Connecticut.
U.S. District Court for the District of Connecticut
U.S. District Court for the District of Connecticut
Federal court
Overseeing settlements and the claims process

Federal court in Hartford, Connecticut, where the consolidated cases are pending.

Timeline

August 2026 March 2027

6 events Latest: October 16th, 2026 · 4 weeks ago
Tap a bar to jump to that date

  1. Claims deadline

    Upcoming Deadline

    Deadline for consumers to file claims for compensation from the settlement funds.

  2. First trial against remaining manufacturers

    Upcoming Legal

    Trial against other generic drug manufacturers is set to begin in Hartford, Connecticut.

  3. Judge grants preliminary approval to Sandoz settlement

    Latest Legal

    A federal judge gave preliminary approval to the $400 million Sandoz settlement. The formal notice of the allocation and distribution plan was published on October 19.

  4. Motion for preliminary approval filed

    Legal

    States filed a motion for preliminary approval of the Sandoz settlement in the U.S. District Court for the District of Connecticut.

  5. States seek approval of Ascend, Citron and Mayne settlements

    Legal

    A bipartisan coalition of 45 states and territories asked the U.S. District Court for the District of Connecticut to approve settlements with Ascend Laboratories, Citron Pharma and Mayne Pharma over alleged price-fixing. The announcements did not disclose the amounts.

  6. Sandoz settlement in principle announced

    Legal

    States announced a $400 million settlement in principle with Sandoz over generic drug price-fixing allegations.

Scenarios

1

Consumers receive settlement payments

Likely Resolves by End of 2027

Discussed by: State attorneys general, court filings

After the March 8, 2027 claims deadline, the claims administrator reviews submissions and the court grants final approval. Eligible consumers receive payments via PayPal, Venmo, Zelle, or mailed check.

2

Objections delay or modify the distribution plan

Possible Resolves by Oct 31, 2027

Discussed by: Court filings, consumer advocates

Consumers or other parties can file objections by August 14, 2027. The court may modify the plan, delay payments, or hold hearings on the objections.

3

Trial leads to additional settlements

Possible Resolves by Q2 2027

Discussed by: State attorneys general press releases

The first trial against remaining drug manufacturers begins in February 2027. The trial could lead to additional settlements, expanding the consumer restitution fund.

Historical Context

2 moments from history that rhyme with this story — and how they unfolded.

1999

Vitamin price-fixing cartel (1999)

Hoffmann-La Roche and BASF pleaded guilty to fixing prices of vitamins sold worldwide. Roche paid $500 million and BASF paid $225 million in criminal fines, the largest antitrust penalties at the time.

Then

The companies paid over $1 billion in total fines and faced civil lawsuits from customers.

Now

The case showed that global price-fixing conspiracies could be prosecuted in U.S. courts and set a precedent for large antitrust fines.

Why this matters now

Demonstrates how large-scale price-fixing conspiracies are prosecuted and how restitution reaches affected buyers.

2021-2022

Opioid settlement distributions (2021-2022)

Johnson & Johnson and three drug distributors agreed to pay up to $26 billion to settle claims that they fueled the opioid crisis. States and local governments received funds through structured distribution plans.

Then

States received billions for addiction treatment and prevention programs.

Now

Established a model for state attorneys general managing large-scale consumer and community restitution.

Why this matters now

Shows how state attorneys general distribute large settlement funds through structured plans.

Sources

(15)
+9
PR Newswire California Department of Justice Colorado Attorney General Oregon Department of Justice New York State Office of the Attorney General New York State Office of the Attorney General South Carolina Attorney General MLex Michigan Business Network VitalLaw Washington State Office of the Attorney General Idaho Office of the Attorney General Settlement Insight PR Newswire Oregon Department of Justice